TY - JOUR T1 - Gene therapy with HGF cDNA in patients on peritoneal dialysis JF - Journal of Clinical Pathology JO - J Clin Pathol SP - 781 LP - 782 DO - 10.1136/jcp.2007.053827 VL - 61 IS - 6 AU - Y Maeda AU - T Matsuoka AU - K Matsuo AU - Y Naiki AU - M Sakaguchi AU - H Hasegawa Y1 - 2008/06/01 UR - http://jcp.bmj.com/content/61/6/781.abstract N2 - Continuous ambulatory peritoneal dialysis (CAPD) is an effective therapy for the treatment of patients with end-stage renal failure.1 Peritoneal fibrosis is one of the most common morphological changes observed in long-term CAPD patients and includes loss of mesothelial cells and severe accumulation of collagen fibres.2 The prevention of peritoneal fibrosis is necessary for maintenance of long-term CAPD. It has previously been reported that transforming growth factor-beta 1 … ER -